Intra-cellular therapies announces presentations at the 2024 european college of neuropsychopharmacology congress

Oral and poster presentations of results from study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd)

ITCI Ratings Summary

ITCI Quant Ranking